| Market Cap | 165.82M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -7.27M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -25.00% |
| Sales | 45.76k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -41.00% |
| Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -93.00% | |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 254.83M | 52W Low Chg | - |
| Insider Own | - | ROA | - | Shares Float | - | Beta | -1.05 |
| Inst Own | 2.03% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00060 |
| Gross Margin | -192.43% | Profit Margin | - | Avg. Volume | 1,505,506 | Target Price | - |
| Oper. Margin | -5,889.82% | Earnings Date | - | Volume | 1 | Change | 0.00% |
Allstar Health Brands, Inc., a specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. The company holds the Tapout license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company was founded in 1997 and is headquartered in Toronto, Canada.
